This week GSK Nigeria (GLAXOSMI) announced that its profits through the first nine months of 2014 dropped 23% compared to the same time period last year.
The news came as a bitter pill to investors. The stock has fallen nearly 16% over the past thirty days and now trades at its lowest price in 16 months.
Are the shares bad medicine? Just what the doctor ordered? Or something in between?
Let’s have a closer look at the numbers and see what they reveal.Read More...